Amarantus Bioscience Holdings Net Profit Margin 2010-2016 | AMBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Amarantus Bioscience Holdings net profit margin from 2010 to 2016. Net profit margin can be defined as net Income as a portion of total sales revenue.

Amarantus Bioscience Holdings Net Profit Margin 2010-2016 | AMBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Amarantus Bioscience Holdings net profit margin from 2010 to 2016. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$146.6B
CVS Health (CVS)	$81.9B
Elevance Health (ELV)	$77B
Cencora (COR)	$57.2B
DiDi Global (DIDIY)	$24.2B
Natera (NTRA)	$21.9B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.7B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.2B
Revvity (RVTY)	$12B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.3B
Avantor (AVTR)	$9.3B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.2B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$6.7B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.8B
Alignment Healthcare (ALHC)	$2.6B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2B